Editor's Choice for August 2018
22 Aug 2018
Editor's Choice for August 2018
New important compounds for targeted and immunotherapies for lung cancer
Updates from a range of lung cancer studies
Large B-cell lymphoma: ZUMA-1 trial
Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227
Pharmacists and precision oncology
Involving pharmacists in oral oncology treatments
Two important pancreatic studies: PRODIGE 24 and PREOPANC
Several important studies for lung cancer
Key advances in ALL and AML
Four studies about relapsed myeloma and advanced disease
Stephan Kiefer outlines the iManageCancer platform